|
|
Volumn 18, Issue 34, 2011, Pages 5172-5173
|
|
Targeting the microenvironment in hematological malignancies: How to condition both stromal and effector cells to overcome cancer spreading
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE;
ADENYLATE CYCLASE;
BORTEZOMIB;
CYCLIC AMP;
CYCLOOXYGENASE 2 INHIBITOR;
DASATINIB;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMATINIB;
IMMUNOMODULATING AGENT;
LENALIDOMIDE;
LIPOPEPTIDE;
NILOTINIB;
PROSTAGLANDIN E2;
THALIDOMIDE;
TOLL LIKE RECEPTOR;
TOLL LIKE RECEPTOR AGONIST;
ANGIOGENESIS;
CANCER INHIBITION;
CANCER SURVIVAL;
CELL ACTIVATION;
CELL FUNCTION;
CELL INTERACTION;
CELL MATURATION;
CHRONIC MYELOID LEUKEMIA;
DENDRITIC CELL;
EDITORIAL;
EFFECTOR CELL;
ENDOTHELIUM CELL;
GAMMA DELTA T LYMPHOCYTE;
HUMAN;
HYPOXIC CELL;
IMMUNE DEFICIENCY;
INTRACELLULAR SIGNALING;
LIPID BLOOD LEVEL;
LYMPHOMA;
METASTASIS;
MULTIPLE MYELOMA;
MYELOMA CELL;
NATURAL KILLER CELL;
REGULATORY T LYMPHOCYTE;
STEM CELL;
STROMA CELL;
T LYMPHOCYTE;
TUMOR IMMUNITY;
TUMOR MICROENVIRONMENT;
ANIMALS;
DISEASE PROGRESSION;
HEMATOLOGIC NEOPLASMS;
HUMANS;
NEOPLASM INVASIVENESS;
STROMAL CELLS;
TUMOR MICROENVIRONMENT;
|
|
EID: 82255195401
PISSN: 09298673
EISSN: 1875533X
Source Type: Journal
DOI: 10.2174/092986711798184235 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
